All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants

    KCE Reports 54 (2007)

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-rotavirus-vaccination-of-belgian-infants

  2. [Evaluation of universal and targeted hepatitis A vaccination programs in Belgium]

    KCE Reports 98 (2008)

    https://kce.fgov.be/en/evaluation-of-universal-and-targeted-hepatitis-a-vaccination-programs-in-belgium

  3. Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study

    KCE Reports 127 (2010)

    https://kce.fgov.be/en/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-1-literature-review

  4. [Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium]

    KCE Reports 151 (2010)

    https://kce.fgov.be/en/cost-utility-of-vaccination-against-chickenpox-in-children-and-against-herpes-zoster-in-elderly-in

  5. Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood

    KCE Reports 155 (2011)

    https://kce.fgov.be/en/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childhood

  6. [Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]

    KCE Reports 157 (2011)

    https://kce.fgov.be/en/economic-evaluation-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium
  7. Hepatitis C: Screening en Preventie

    [Hepatitis C: Screening and Prevention]

    KCE Reports 173 (2012)

    https://kce.fgov.be/en/hepatitis-c-screening-and-prevention

  8. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  9. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study